Page 6 - Edwards SAPIEN 3 Ultra Implanter Brochure
P. 6
Engineered for your patient's long-term future
Percentage of patients experiencing paravalvular leak at 30 Days2
≥ Moderate Mild 100
None/Trace
12.9
87.1
50
0
Edwards SAPIEN 3 Ultra valve features uniform sealing designed to minimize PVL.
30 Days (N=70)
30-Day findings were Core Lab adjudicated.
SAPIEN 3 Ultra valve Study
30-day findings were core lab adjudicated.
Percent of patients